] . 2014. “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant To Hypomethylating Therapy Or Best Supportive Care In Patients Aged 50 To 75 With Intermediate-2 And High-Risk Myelodysplastic Syndrome: Blood And M”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1566-72. doi:10.1016/j.bbmt.2014.06.010.